Inventor · disambiguated record
Maxime Feyeux
Also filed as: FEYEUX MAXIME
5 granted patents·19 pending applications·4 citations·filing 2017–2025
69Inventor score
Top patents by PatentIndex Score
24 records- 0183US11511254B2Process for producing capsules made of an external shell of crosslinked hydrogel surrounding a central coreUNIV BORDEAUX·Filed 2018·Granted Nov 29, 2022·3 cites·10 claims
- 0281US11807870B2Cellular microcompartment and preparation processesUNIV BORDEAUX·Filed 2017·Granted Nov 7, 2023·1 cites·15 claims
- 0380US2025059504A1Cellular microcompartment and preparation processesUNIV BORDEAUX·Filed 2024·Application pending·0 cites
- 0478US12146153B2Cellular microcompartment and preparation processesUNIV BORDEAUX·Filed 2022·Granted Nov 19, 2024·0 cites·8 claims
- 0578US2024018469A1Cellular microcompartment and preparation processesUNIV BORDEAUX·Filed 2023·Application pending·0 cites
- 0674US12435307B2Neural tissue unit and use of such a unit for implantation into the nervous system of a mammalUNIV BORDEAUX·Filed 2023·Granted Oct 7, 2025·0 cites·30 claims
- 0768US2025304909A1System for cell culture in a bioreactorUNIV BORDEAUX·Filed 2025·Application pending·0 cites
- 0867US2025223551A1Cellular microcompartments comprising lymphocytes forming a grouped 3d culture and having a low tnf alpha contentTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0967US2025243460A1Cellular microcompartments comprising lymphocytes forming a 3d grouped culture and having a low granzyme b contentTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1063US2024043793A1Extracellular matrix substitute in a cellular microcompartmentTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1160US2025297228A1Specific three-dimensional liver microtissue and uses in the treatment of liver failureTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1260US2024123443A1Connection deviceTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1360US2025302884A1Specific liver microtissue comprising at least three different phenotypes of hepatocytes, and uses thereofTREEFROG THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1458US12448601B2Neural tissue unit and use of such a unit for implantation into the nervous system of a mammalUNIV BORDEAUX·Filed 2017·Granted Oct 21, 2025·0 cites·9 claims
- 1558US2023357725A1Liver microtissue and uses in treatment of liver failureTREEFROG THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1655US2023355683A1Liver microtissue for treating liver failureTREEFROG THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1754US2021123013A1System for cell culture in a bioreactorUNIV BORDEAUX·Filed 2019·Application pending·0 cites
- 1851US2024301346A1Cellular microcompartments comprising cells of which the genomic integrity is maintained after amplification and preparation methodTREEFROG THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1951US2024060025A1Large cellular microcompartments comprising a plurality of cystsTREEFROG THERAPEUTICS·Filed 2022·Application pending·0 cites
- 2050US2022356445A1Method for in-vitro production of mammalian neuronsUNIV BORDEAUX·Filed 2020·Application pending·0 cites
- 2149US2022273727A1Hollow three-dimensional unit made from retinal tissue and use thereof in the treatment of retinopathiesTREEFROG THERAPEUTICS·Filed 2020·Application pending·0 cites
- 2245US2023407260A1Particular cardiac tissue and its use in the treatment of cardiac pathologiesTREEFROG THERAPEUTICS·Filed 2021·Application pending·0 cites
- 2341US2023358728A1Cellular microcompartments comprising human cells undergoing cardiac differentiation, tissues obtained from these microcompartments and usesTREEFROG THERAPEUTICS·Filed 2021·Application pending·0 cites
- 2438US2020002681A1Hollow cellular microfibre and method for producing such a hollow cellular microfibreUNIV BORDEAUX·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maxime Feyeux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →